Brain cancer battle: Triple-Threat trial combines drug, diet, and diabetes pill
NCT ID NCT05183204
Summary
This study is testing a three-part treatment for glioblastoma, a serious brain cancer. It combines a new drug called paxalisib with a high-fat, low-carb ketogenic diet and metformin, a common diabetes medication. The goal is to see if this combination is safe and can help control the cancer by stopping it from growing for longer. The trial is for adults with either newly diagnosed or recurring glioblastoma.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Weill Cornell Medicine
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.